In pancreatic cancer, glutamine deprivation has been shown to reduce GPX4 expression, a central regulator of ferroptosis, thus sensitizing cells to ferroptosis through the KRAS/MAPK-NRF2-GPX4 pathway [70]. The gene discussed is GPX4; the disease is pancreatic neoplasm.